MEDP
Medpace Holdings, Inc.
Services-Commercial Physical & Biological Research- 売上
- $2.5bn
- 時価総額
- $17.6bn
株価 $578.30 · 100株 6万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $1.9bn | $2.1bn | $2.5bn |
| 成長率 | — | 11.8% | 20.0% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | $161m | $180m | $198m |
| 販管費率 | 8.6% | 8.5% | 7.8% |
| 営利 | $337m | $447m | $535m |
| 営利率 | 17.9% | 21.2% | 21.1% |
| 純利益 | $283m | $404m | $451m |
| PBR | 31.5 | 21.3 | 38.4 |
| PSR | 9.3 | 8.4 | 7.0 |
| PGPR | — | — | — |
| PER | 62 | 44 | 39 |
| ﾈｯﾄｷｬｯｼｭ | $245m | $669m | $497m |
| EV/EBITDA | 47.8 | 35.6 | 30.4 |
| Rule of 40 | — | 33% | 41% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）